These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Search MEDLINE/PubMed


  • Title: The effects of lipoic acid on soybean beta-conglycinin-induced anaphylactic reactions in a rat model.
    Author: Han P, Ma X, Yin J.
    Journal: Arch Anim Nutr; 2010 Jun; 64(3):254-64. PubMed ID: 20578652.
    Abstract:
    The purpose of this study was to evaluate the effects of feeding a low dose of lipoic acid on attenuating soybean beta-conglycinin-induced hypersensitivity using a rat model, with ovalbumin as the positive allergic control. Forty-eight recently weaned male Sprague-Dawley rats were assigned to four treatments and fed a cornstarch-casein-based diet either unsupplemented (Groups I, II and III) or supplemented with 25 mg/kg lipoic acid (Group IV). On days 1, 10, 17, and 24, Groups III and IV were sensitised with 20 mg beta-conglycinin by means of intragastric gavage, while Group II was sensitised with 20 mg ovalbumin and Group I (control) with casein. On day 31, rats received a double dose of beta-conglycinin, ovalbumin or casein, respectively. Ovalbumin-sensitised rats (Group II) and beta-conglycinin-sensitised rats (Group III) demonstrated an increase in serum IgE and histamine release, but reduced growth performance compared to the control (Group 1) (p < 0.05). A low dose of lipoic acid had no effect on average weight gain, but increased villus height in the jejunum (p < 0.05), while reducing serum beta-conglycinin-specific IgE and histamine content in the jejunum. Moreover, lipoic acid supplementation did not significantly affect interferon-gamma or interleukin-4. Taken together, our results suggest that a low dose of lipoic acid could potentially be used as an immunomodulator to attenuate soybean beta-conglycinin induced allergies.
    [Abstract] [Full Text] [Related] [New Search]